归创通桥医疗技术有限公司宣布，向一家参与公司产品研发与生产流程的咨询服务供应商授予25万份股权奖励。该奖励每股定价2.1301元人民币，预计于2026年7月15日正式归属。绩效指标包括财务结果、重大合同达成及关键业务里程碑实现情况。此外，方案设有追回条款，董事会可酌情取消奖励。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.